STEM-Talk

Dawn Kernagis and Ken Ford

Dive into the fascinating world of science and technology with "STEM-Talk," hosted by Dawn Kernagis and Ken Ford. This podcast offers listeners an unparalleled opportunity to explore groundbreaking research and insights from the leading minds in science, engineering, and medicine. Each episode delves into conversations with distinguished researchers and innovators, unpacking complex scientific concepts and discussing their real-world applications. Whether you're a science enthusiast or a professional in the field, "STEM-Talk" provides a unique platform to discover the latest advancements and trends shaping our future. The show’s hosts, Dr. Dawn Kernagis, a bioastronautics researcher, and Dr. Ken Ford, an AI and computer science expert, bring their deep knowledge and infectious curiosity to every discussion. Together, they ensure that "STEM-Talk" is not just informative but also engaging, making cutting-edge science accessible to a broader audience. Tune in to "STEM-Talk" to stay connected with the evolving world of STEM and be inspired by the stories of innovation and discovery that are driving progress in every corner of the globe.

Episodes

  • Episode 166: Vyvyane Loh and Ken Ford discuss atherosclerotic heart disease

    In this insightful episode, Dr. Jonathan Edwards, an anesthesiologist and medical practitioner, shares his extensive experience using ketamine in clinical settings. He discusses its development, initial medical uses, and significant effectiveness in treating depression and suicidal ideation, highlighting its safety when used under medical supervision despite its potential for abuse. The episode delves into the complexities of ketamine's impact on mental health, addressing both its therapeutic potentials and the risks associated with its misuse. The conversation also touches upon the broader implications of psychedelic therapies in mental health, advocating for combined approaches involving both medication and psychotherapy to ensure effective treatment outcomes.